Form 8-K - Current report:
SEC Accession No. 0000950103-25-009253
Filing Date
2025-07-24
Accepted
2025-07-24 17:20:54
Documents
12
Period of Report
2025-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp232033_8k.htm   iXBRL 8-K 27764
  Complete submission text file 0000950103-25-009253.txt   191192

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE amrx-20250724.xsd EX-101.SCH 3008
3 XBRL LABEL FILE amrx-20250724_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE amrx-20250724_pre.xml EX-101.PRE 22354
14 EXTRACTED XBRL INSTANCE DOCUMENT dp232033_8k_htm.xml XML 3576
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 251147927
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)